<< Previous | 11 of 20 | Next >>

Uk News

Puberty blocker: drug companies’ shares fall after landmark transgender case

The companies behind controversial puberty blockers at the centre of a landmark transgender ruling have seen their share prices dip.

en staff

Figure Image

The firms, AbbVie Inc and Takeda, saw the value of their shares fall in the aftermath of the Kiera Bell case.